Yoshinari Miyata

Yoshinari Miyata is the Chief Innovation Officer at PhoenixBio. Prior to this role, Miyata held various leadership positions in research planning, business development, and scientific affairs at PhoenixBio, Replicore, LLC., and various departments at the University of Michigan. Miyata's research background includes identifying novel anti-cancer drugs, developing treatment options for chronic low back pain, and discovering molecules that inhibit heat shock protein 70. Miyata holds a Ph.D. in Chemical Biology from the University of Michigan, as well as degrees from the University of Tokyo.